The International AIDS Conference brings together science, leadership, and community to advance treatment and prevention of HIV.
You can find DNDi in the Exhibition Hall at Booth #215!
Side Event
Diagnose, Treat, Innovate: A paradigm shift for ending paediatric AIDS
Co-organized by the African Society for Laboratory Medicine (ASLM), the Clinton Health Access Initiative (CHAI), DNDi, Elizabeth Glaser Pediatrics AIDS Foundation, and Unitaid
Date: Monday, 23 July 2018
Time: 12:30-14:30
Venue: Hall 11B
Speakers:
- Smiljka de Lussigny, Programme Manager HIV and HCV diagnostics, Unitaid
- Ndlovu Nqobile, Project Director, ASLM
- Trevor Peter, Senior Scientific Director Diagnostics, CHAI
- Rebecca Bailey, Associate Director, Point-of-Care Early Infant Diagnosis Project, Elizabeth Glaser Pediatrics AIDS Foundation
- Victor Musiime, Senior Lecturer at Makerere University, College of Health Sciences, Department of Paediatrics and Child Health, Uganda
- Chewe Luo, Chief of HIV/AIDS, Programme Division, UNICEF
- George Siberry, Director for HIV Treatment, Care & TB, Senior Pediatric Technical Advisor, PEPFAR
- Surbhi Modi, Chief, Maternal and Child Health Branch, Centers for Disease Control and Prevention
RSVP: amataka@aslm.org
Session
ART in infants and children
Date: Wednesday, 25 July 2018
Time: 14:30-16:00
Venue: Hall 10
| Pellet formulation of lopinavir/ritonavir in children: 48-week evolution of viral suppression across age categories in the LIVING study Andrieux-Meyer I, Salami O, Omollo R, Musiime V, Wamalwa D*, Maleche Obimbo E, Kekitiinwa A, Mwanga-Amumpaire J, Oyaro P, Bukusi EA, Waweru M, Wasunna M, Lee J, Simon F, Lallemant M, for the LIVING STUDY GROUP |
*Presenting author
Panel Discussion
Moving beyond HIV and planning the next steps
Date: Monday, 23 July 2018
Time: 12:00
Venue: Hall 11B
Speakers:
- Martina Penazzato, Paediatric HIV technical advisor, WHO, Switzerland
- Paul Domanico, Senior Director of Research & Development, Clinton Health Access Initiative, United States
- Wiweka Kaszubska, Vice President, Head of Product Development Research & Development, Medicines for Malaria Venture, Switzerland
- Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes, DNDi, Switzerland
- George Siberry, Director for HIV Treatment, Care & TB, Senior Pediatric Technical Advisor, PEPFAR
- Robert Matiru, Director of Operations, UNITAID, Switzerland
- Taryn Barker, Manager, Saving Lives, Children’s Investment Fund Foundation, United Kingdom
How can future collaborative African HIV research address barriers to the development, use, delivery and access to HIV interventions in sub-Saharan Africa?
Date: Thursday, 26 July 2018
Time: 7:45
Venue: Hall 11B
Speakers:
- François Bompart, Director of Paediatric HIV/HCV Programmes, DNDi, Switzerland
- Andrew Kambugu, Executive Director, Infectious Diseases Institute (IDI), Makerere University, Uganda
- Prince Bahati, Executive Director Global Affairs, IAVI, Kenya
- Fareed Abdullah, Director, Office of AIDS and TB Research, (SAMRC), South Africa
Poster Discussion
Antiretrovirals: Pharmacokinetics and generics
Date: Wednesday, 25 July 2018
Time: 13:00-14:00
Venue: Emerald Room
TB/HIV co-treatment with super-boosted lopinavir and anti-tuberculosis treatment lowers abacavir concentration in children |
*Presenting author
Poster
Whether and why caregivers adhere to oral lopinavir/ritonavir pellets: lessons for scaling up an innovative pediatric HIV treatment in Kenya |
*Presenting author
Pre-Conference
10th Workshop on HIV Paediatrics
Date: 20-21 July 2018
Pellet formulation of lopinavir/ritonavir in children: 48-week evolution of viral suppression across age categories in the LIVING study |
*Presenting author
More information:
